IMMUNITAS
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Jul 2023)
What this means for you
This application is over — abandoned 24 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88731767
- Mark type
- Stylized text
- Filed
- 18 Dec 2019
- Published for opposition
- 28 Apr 2020
- Abandoned
- 24 Jul 2023
- Attorney of record
- Joshua Jarvis
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Immunitas Therapeutics, Inc., Waltham, MA, US
- Immunitas Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 24 Jul 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Jul 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Jan 2023 — CORRECTED NOA E-MAILED
- 30 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Dec 2022 — DIVISIONAL PROCESSING COMPLETE
- 01 Dec 2022 — DIVISIONAL REQUEST RECEIVED
- 29 Dec 2022 — SOU EXTENSION 5 GRANTED
- 01 Dec 2022 — SOU EXTENSION 5 FILED
- 29 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2022 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 10 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2022 — SOU EXTENSION 4 GRANTED
- 06 May 2022 — SOU EXTENSION 4 FILED
- 06 May 2022 — SOU TEAS EXTENSION RECEIVED